beta Amyloid Antikörper
Kurzübersicht für beta Amyloid Antikörper (ABIN1990945)
Target
Alle beta Amyloid (Abeta) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Anti-mAB-O | Mouse anti-human Abeta protein (3-10) region, oligomer-specific (clone 3E5,F8)
-
Kreuzreaktivität (Details)
-
Human
Not reactive in: No confirmed exceptions from predicted reactivity are currently known -
Homologie
- Mouse,Bovine,Chicken,Dog,Porcine,Rabbit
-
Aufreinigung
- Immunogen affinity purified serum
-
Immunogen
- Synthetic peptide chosen from human Abeta (1-42) protein.
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- 10 μg/mL (IL), 1-2 μg/mL (Dot), 1 μg/mL (ELISA capture)
-
Kommentare
-
Immunolocalization: human tissue was paraffin-embedded and sectioned. De-waxed and rehydrated in an ethanol gradient. Antigens were retrieved in sodium citrate buffer (pH 6) at 95°C for 1 h. The tissue sections were separately incubated for 1 h at RT with primary antibody and antibody binding was visualized with IgG Preoxidase Reagent Kit.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- For reconstitution add 50 μL of sterile water
-
Buffer
- Immunogen affinity purified serum in PBS pH 7.4.
-
Handhabung
- Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store lyophilized/reconstituted at -20°C, once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube.
-
-
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
-
Andere Bezeichnung
- Abeta
-
Hintergrund
- Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A hallmark of AD is the accumulation of plaques in the brain of AD patients. The plaques predominantly consist of aggregates of amyloid-beta (Abeta), a peptide of 39-42 amino acids generated in vivo by specific, proteolytic cleavage of the amyloid precursor protein. Recent findings however suggest that smaller oligomeric forms of Abeta, formed in parallel to the amyloid plaques, excert the predominant tissue damaging effect.Specific identification of the oligomeric forms is as a consequence of great interest. Based on a recently published technique a highly oligomer-specific antibody (mAB-O), targeting Abeta oligomers while omitting reactivity towards the monomeric and fibrillar counterpart, has been developed.
-
Molekulargewicht
- 4.5 kDa
-
Pathways
- Inflammasome
Target
-